QTERN is a prescription medicine that contains dapagliflozin and saxagliptin. Each belongs to a group of medicines called “oral anti-diabetics”
QTERN is used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. QTERN is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
| Trade Name | QTERN |
|---|---|
| Generic Name | Saxagliptin / Dapagliflozin |
| Manufacturer | AstraZeneca Pharmaceuticals LP |
| Drug Type | Cardiodiabetic |
| Indication | Antidiabetic |
| Doasage Form | Tablet |
| Packaging | 2 x 14 tablets 5mg/10mg |
